We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu
IMPORTANT: Due to the lapse in government funding, the information on this web site may not be up to date, transactions submitted via the web site may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Positron Emission Mammography (PEM) Biopsy Accessory for the Diagnosis of Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00981812
Recruitment Status : Completed
First Posted : September 22, 2009
Results First Posted : April 4, 2016
Last Update Posted : April 4, 2016
Information provided by (Responsible Party):

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment;   Masking: None (Open Label);   Primary Purpose: Diagnostic
Condition: Breast Cancer
Intervention: Procedure: PEM Breast Biopsy

  Participant Flow

Recruitment Details
Key information relevant to the recruitment process for the overall study, such as dates of the recruitment period and locations
Recruited from 02/2010 to 06/2011 from University of Cincinnati Medical Center, Radiology Department, Breast Imaging.

Pre-Assignment Details
Significant events and approaches for the overall study following participant enrollment, but prior to group assignment
No text entered.

Reporting Groups
PEM Breast Biopsy PEM Breast Biopsy: Breast biopsy using PEM guidance and Stereo Navigator software

Participant Flow:   Overall Study
    PEM Breast Biopsy

  Baseline Characteristics

Population Description
Explanation of how the number of participants for analysis was determined. Includes whether analysis was per protocol, intention to treat, or another method. Also provides relevant details such as imputation technique, as appropriate.
Women 25 or older

Reporting Groups
Primary Women 25 years or older with a highly suspicious finding for possible breast cancer on mammography and/or ultrasound, who are to be scheduled for percutaneous breast biopsy.

Baseline Measures
Overall Participants Analyzed 
[Units: Participants]
Age [1] 
[Units: Participants]
<=18 years   0 
Between 18 and 65 years   17 
>=65 years   3 
[1] Women 25 years of age or older with a highly suspicious breast mass recommended to biopsy.
[Units: Participants]
Female   20 
Male   0 

  Outcome Measures

1.  Primary:   Feasibility That Breast Biopsy Can be Performed Using PEM and Stereo Navigator Software After Diagnostic PEM on the Same Day.   [ Time Frame: At time of biopsy ]

  Serious Adverse Events

  Other Adverse Events

  Limitations and Caveats

Limitations of the study, such as early termination leading to small numbers of participants analyzed and technical problems with measurement leading to unreliable or uninterpretable data
No text entered.

  More Information

Certain Agreements:  
Principal Investigators are NOT employed by the organization sponsoring the study.
There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

Results Point of Contact:  
Name/Title: Mary Mahoney, MD
Organization: University of Cincinnati Medical Center
phone: 513-584-4396
e-mail: mary.mahoney@uchealth.com

Responsible Party: Mary Mahoney, University of Cincinnati
ClinicalTrials.gov Identifier: NCT00981812     History of Changes
Other Study ID Numbers: Cincinnati-01
First Submitted: September 18, 2009
First Posted: September 22, 2009
Results First Submitted: December 23, 2014
Results First Posted: April 4, 2016
Last Update Posted: April 4, 2016